Global Interleukin 17A Market Insights and Forecast to 2026

Publisher Name :
Date: 01-Jul-2020
No. of pages: 111
Inquire Before Buying

Interleukin 17A market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interleukin 17A market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Interleukin 17A market is segmented into

- ABY-035

- CNTO-6785

- DLX-2882

- Others

Segment by Application, the Interleukin 17A market is segmented into

- Chronic Pain

- Liver Cancer

- Kidney Cancer

- Others

Regional and Country-level Analysis

The Interleukin 17A market is analysed and market size information is provided by regions (countries).

The key regions covered in the Interleukin 17A market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Interleukin 17A Market Share Analysis

Interleukin 17A market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interleukin 17A business, the date to enter into the Interleukin 17A market, Interleukin 17A product introduction, recent developments, etc.

The major vendors covered:

- AbbVie Inc

- Abeome Corporation

- Affibody AB

- Cell Medica Limited

- Eli Lilly and Company

- Johnson & Johnson

- Merck KGaA

- Novartis AG

- Orega Biotech SAS

Global Interleukin 17A Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Interleukin 17A Product Introduction
1.2 Market Segments
1.3 Key Interleukin 17A Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Interleukin 17A Market Size Growth Rate by Type
1.4.2 ABY-035
1.4.3 CNTO-6785
1.4.4 DLX-2882
1.4.5 Others
1.5 Market by Application
1.5.1 Global Interleukin 17A Market Size Growth Rate by Application
1.5.2 Chronic Pain
1.5.3 Liver Cancer
1.5.4 Kidney Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Interleukin 17A Market Size, Estimates and Forecasts
2.1.1 Global Interleukin 17A Revenue 2015-2026
2.1.2 Global Interleukin 17A Sales 2015-2026
2.2 Global Interleukin 17A, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Interleukin 17A Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Interleukin 17A Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Interleukin 17A Competitor Landscape by Players
3.1 Interleukin 17A Sales by Manufacturers
3.1.1 Interleukin 17A Sales by Manufacturers (2015-2020)
3.1.2 Interleukin 17A Sales Market Share by Manufacturers (2015-2020)
3.2 Interleukin 17A Revenue by Manufacturers
3.2.1 Interleukin 17A Revenue by Manufacturers (2015-2020)
3.2.2 Interleukin 17A Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Interleukin 17A Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Interleukin 17A Revenue in 2019
3.2.5 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Interleukin 17A Price by Manufacturers
3.4 Interleukin 17A Manufacturing Base Distribution, Product Types
3.4.1 Interleukin 17A Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interleukin 17A Product Type
3.4.3 Date of International Manufacturers Enter into Interleukin 17A Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Interleukin 17A Market Size by Type (2015-2020)
4.1.1 Global Interleukin 17A Sales by Type (2015-2020)
4.1.2 Global Interleukin 17A Revenue by Type (2015-2020)
4.1.3 Interleukin 17A Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Interleukin 17A Market Size Forecast by Type (2021-2026)
4.2.1 Global Interleukin 17A Sales Forecast by Type (2021-2026)
4.2.2 Global Interleukin 17A Revenue Forecast by Type (2021-2026)
4.2.3 Interleukin 17A Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Interleukin 17A Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Interleukin 17A Market Size by Application (2015-2020)
5.1.1 Global Interleukin 17A Sales by Application (2015-2020)
5.1.2 Global Interleukin 17A Revenue by Application (2015-2020)
5.1.3 Interleukin 17A Price by Application (2015-2020)
5.2 Interleukin 17A Market Size Forecast by Application (2021-2026)
5.2.1 Global Interleukin 17A Sales Forecast by Application (2021-2026)
5.2.2 Global Interleukin 17A Revenue Forecast by Application (2021-2026)
5.2.3 Global Interleukin 17A Price Forecast by Application (2021-2026)
6 North America
6.1 North America Interleukin 17A by Country
6.1.1 North America Interleukin 17A Sales by Country
6.1.2 North America Interleukin 17A Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Interleukin 17A Market Facts & Figures by Type
6.3 North America Interleukin 17A Market Facts & Figures by Application
7 Europe
7.1 Europe Interleukin 17A by Country
7.1.1 Europe Interleukin 17A Sales by Country
7.1.2 Europe Interleukin 17A Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Interleukin 17A Market Facts & Figures by Type
7.3 Europe Interleukin 17A Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Interleukin 17A by Region
8.1.1 Asia Pacific Interleukin 17A Sales by Region
8.1.2 Asia Pacific Interleukin 17A Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Interleukin 17A Market Facts & Figures by Type
8.3 Asia Pacific Interleukin 17A Market Facts & Figures by Application
9 Latin America
9.1 Latin America Interleukin 17A by Country
9.1.1 Latin America Interleukin 17A Sales by Country
9.1.2 Latin America Interleukin 17A Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Interleukin 17A Market Facts & Figures by Type
9.3 Central & South America Interleukin 17A Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Interleukin 17A by Country
10.1.1 Middle East and Africa Interleukin 17A Sales by Country
10.1.2 Middle East and Africa Interleukin 17A Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Interleukin 17A Market Facts & Figures by Type
10.3 Middle East and Africa Interleukin 17A Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Interleukin 17A Products Offered
11.1.5 AbbVie Inc Related Developments
11.2 Abeome Corporation
11.2.1 Abeome Corporation Corporation Information
11.2.2 Abeome Corporation Description and Business Overview
11.2.3 Abeome Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abeome Corporation Interleukin 17A Products Offered
11.2.5 Abeome Corporation Related Developments
11.3 Affibody AB
11.3.1 Affibody AB Corporation Information
11.3.2 Affibody AB Description and Business Overview
11.3.3 Affibody AB Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Affibody AB Interleukin 17A Products Offered
11.3.5 Affibody AB Related Developments
11.4 Cell Medica Limited
11.4.1 Cell Medica Limited Corporation Information
11.4.2 Cell Medica Limited Description and Business Overview
11.4.3 Cell Medica Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cell Medica Limited Interleukin 17A Products Offered
11.4.5 Cell Medica Limited Related Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Description and Business Overview
11.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly and Company Interleukin 17A Products Offered
11.5.5 Eli Lilly and Company Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Interleukin 17A Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Merck KGaA
11.7.1 Merck KGaA Corporation Information
11.7.2 Merck KGaA Description and Business Overview
11.7.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck KGaA Interleukin 17A Products Offered
11.7.5 Merck KGaA Related Developments
11.8 Novartis AG
11.8.1 Novartis AG Corporation Information
11.8.2 Novartis AG Description and Business Overview
11.8.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis AG Interleukin 17A Products Offered
11.8.5 Novartis AG Related Developments
11.9 Orega Biotech SAS
11.9.1 Orega Biotech SAS Corporation Information
11.9.2 Orega Biotech SAS Description and Business Overview
11.9.3 Orega Biotech SAS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Orega Biotech SAS Interleukin 17A Products Offered
11.9.5 Orega Biotech SAS Related Developments
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Interleukin 17A Products Offered
11.1.5 AbbVie Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Interleukin 17A Market Estimates and Projections by Region
12.1.1 Global Interleukin 17A Sales Forecast by Regions 2021-2026
12.1.2 Global Interleukin 17A Revenue Forecast by Regions 2021-2026
12.2 North America Interleukin 17A Market Size Forecast (2021-2026)
12.2.1 North America: Interleukin 17A Sales Forecast (2021-2026)
12.2.2 North America: Interleukin 17A Revenue Forecast (2021-2026)
12.2.3 North America: Interleukin 17A Market Size Forecast by Country (2021-2026)
12.3 Europe Interleukin 17A Market Size Forecast (2021-2026)
12.3.1 Europe: Interleukin 17A Sales Forecast (2021-2026)
12.3.2 Europe: Interleukin 17A Revenue Forecast (2021-2026)
12.3.3 Europe: Interleukin 17A Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Interleukin 17A Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Interleukin 17A Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Interleukin 17A Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Interleukin 17A Market Size Forecast by Region (2021-2026)
12.5 Latin America Interleukin 17A Market Size Forecast (2021-2026)
12.5.1 Latin America: Interleukin 17A Sales Forecast (2021-2026)
12.5.2 Latin America: Interleukin 17A Revenue Forecast (2021-2026)
12.5.3 Latin America: Interleukin 17A Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Interleukin 17A Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Interleukin 17A Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Interleukin 17A Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Interleukin 17A Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Interleukin 17A Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interleukin 17A Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Interleukin 17A Market Segments
Table 2. Ranking of Global Top Interleukin 17A Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interleukin 17A Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ABY-035
Table 5. Major Manufacturers of CNTO-6785
Table 6. Major Manufacturers of DLX-2882
Table 7. Major Manufacturers of Others
Table 8. Global Interleukin 17A Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Interleukin 17A Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Interleukin 17A Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Interleukin 17A Sales Market Share by Regions (2015-2020)
Table 12. Global Interleukin 17A Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Interleukin 17A Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Interleukin 17A Sales Share by Manufacturers (2015-2020)
Table 15. Global Interleukin 17A Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Interleukin 17A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 17A as of 2019)
Table 17. Interleukin 17A Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Interleukin 17A Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Interleukin 17A Price (2015-2020) (USD/Pcs)
Table 20. Interleukin 17A Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Interleukin 17A Product Type
Table 22. Date of International Manufacturers Enter into Interleukin 17A Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Interleukin 17A Sales by Type (2015-2020) (K Pcs)
Table 25. Global Interleukin 17A Sales Share by Type (2015-2020)
Table 26. Global Interleukin 17A Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Interleukin 17A Revenue Share by Type (2015-2020)
Table 28. Interleukin 17A Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Interleukin 17A Sales by Application (2015-2020) (K Pcs)
Table 30. Global Interleukin 17A Sales Share by Application (2015-2020)
Table 31. North America Interleukin 17A Sales by Country (2015-2020) (K Pcs)
Table 32. North America Interleukin 17A Sales Market Share by Country (2015-2020)
Table 33. North America Interleukin 17A Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Interleukin 17A Revenue Market Share by Country (2015-2020)
Table 35. North America Interleukin 17A Sales by Type (2015-2020) (K Pcs)
Table 36. North America Interleukin 17A Sales Market Share by Type (2015-2020)
Table 37. North America Interleukin 17A Sales by Application (2015-2020) (K Pcs)
Table 38. North America Interleukin 17A Sales Market Share by Application (2015-2020)
Table 39. Europe Interleukin 17A Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Interleukin 17A Sales Market Share by Country (2015-2020)
Table 41. Europe Interleukin 17A Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Interleukin 17A Revenue Market Share by Country (2015-2020)
Table 43. Europe Interleukin 17A Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Interleukin 17A Sales Market Share by Type (2015-2020)
Table 45. Europe Interleukin 17A Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Interleukin 17A Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Interleukin 17A Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Interleukin 17A Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Interleukin 17A Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Interleukin 17A Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Interleukin 17A Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Interleukin 17A Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Interleukin 17A Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Interleukin 17A Sales Market Share by Application (2015-2020)
Table 55. Latin America Interleukin 17A Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Interleukin 17A Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Interleukin 17A Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Interleukin 17A Revenue Market Share by Country (2015-2020)
Table 59. Latin America Interleukin 17A Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Interleukin 17A Sales Market Share by Type (2015-2020)
Table 61. Latin America Interleukin 17A Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Interleukin 17A Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Interleukin 17A Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Interleukin 17A Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Interleukin 17A Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Interleukin 17A Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Interleukin 17A Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Interleukin 17A Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Interleukin 17A Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Interleukin 17A Sales Market Share by Application (2015-2020)
Table 71. AbbVie Inc Corporation Information
Table 72. AbbVie Inc Description and Major Businesses
Table 73. AbbVie Inc Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. AbbVie Inc Product
Table 75. AbbVie Inc Recent Development
Table 76. Abeome Corporation Corporation Information
Table 77. Abeome Corporation Description and Major Businesses
Table 78. Abeome Corporation Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Abeome Corporation Product
Table 80. Abeome Corporation Recent Development
Table 81. Affibody AB Corporation Information
Table 82. Affibody AB Description and Major Businesses
Table 83. Affibody AB Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Affibody AB Product
Table 85. Affibody AB Recent Development
Table 86. Cell Medica Limited Corporation Information
Table 87. Cell Medica Limited Description and Major Businesses
Table 88. Cell Medica Limited Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Cell Medica Limited Product
Table 90. Cell Medica Limited Recent Development
Table 91. Eli Lilly and Company Corporation Information
Table 92. Eli Lilly and Company Description and Major Businesses
Table 93. Eli Lilly and Company Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Eli Lilly and Company Product
Table 95. Eli Lilly and Company Recent Development
Table 96. Johnson & Johnson Corporation Information
Table 97. Johnson & Johnson Description and Major Businesses
Table 98. Johnson & Johnson Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Johnson & Johnson Product
Table 100. Johnson & Johnson Recent Development
Table 101. Merck KGaA Corporation Information
Table 102. Merck KGaA Description and Major Businesses
Table 103. Merck KGaA Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Merck KGaA Product
Table 105. Merck KGaA Recent Development
Table 106. Novartis AG Corporation Information
Table 107. Novartis AG Description and Major Businesses
Table 108. Novartis AG Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Novartis AG Product
Table 110. Novartis AG Recent Development
Table 111. Orega Biotech SAS Corporation Information
Table 112. Orega Biotech SAS Description and Major Businesses
Table 113. Orega Biotech SAS Interleukin 17A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Orega Biotech SAS Product
Table 115. Orega Biotech SAS Recent Development
Table 116. Global Interleukin 17A Sales Forecast by Regions (2021-2026) (K Pcs)
Table 117. Global Interleukin 17A Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Interleukin 17A Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Interleukin 17A Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Interleukin 17A Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. North America: Interleukin 17A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Interleukin 17A Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Europe: Interleukin 17A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Interleukin 17A Sales Forecast by Region (2021-2026) (K Pcs)
Table 125. Asia Pacific: Interleukin 17A Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Interleukin 17A Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. Latin America: Interleukin 17A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Interleukin 17A Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Middle East and Africa: Interleukin 17A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Interleukin 17A Players
Table 134. Interleukin 17A Customers List
Table 135. Interleukin 17A Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Interleukin 17A Product Picture
Figure 2. Global Interleukin 17A Sales Market Share by Type in 2020 & 2026
Figure 3. ABY-035 Product Picture
Figure 4. CNTO-6785 Product Picture
Figure 5. DLX-2882 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Interleukin 17A Sales Market Share by Application in 2020 & 2026
Figure 8. Chronic Pain
Figure 9. Liver Cancer
Figure 10. Kidney Cancer
Figure 11. Others
Figure 12. Interleukin 17A Report Years Considered
Figure 13. Global Interleukin 17A Market Size 2015-2026 (US$ Million)
Figure 14. Global Interleukin 17A Sales 2015-2026 (K Pcs)
Figure 15. Global Interleukin 17A Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Interleukin 17A Sales Market Share by Region (2015-2020)
Figure 17. Global Interleukin 17A Sales Market Share by Region in 2019
Figure 18. Global Interleukin 17A Revenue Market Share by Region (2015-2020)
Figure 19. Global Interleukin 17A Revenue Market Share by Region in 2019
Figure 20. Global Interleukin 17A Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Interleukin 17A Revenue in 2019
Figure 22. Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Interleukin 17A Sales Market Share by Type (2015-2020)
Figure 24. Global Interleukin 17A Sales Market Share by Type in 2019
Figure 25. Global Interleukin 17A Revenue Market Share by Type (2015-2020)
Figure 26. Global Interleukin 17A Revenue Market Share by Type in 2019
Figure 27. Global Interleukin 17A Market Share by Price Range (2015-2020)
Figure 28. Global Interleukin 17A Sales Market Share by Application (2015-2020)
Figure 29. Global Interleukin 17A Sales Market Share by Application in 2019
Figure 30. Global Interleukin 17A Revenue Market Share by Application (2015-2020)
Figure 31. Global Interleukin 17A Revenue Market Share by Application in 2019
Figure 32. North America Interleukin 17A Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Interleukin 17A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Interleukin 17A Sales Market Share by Country in 2019
Figure 35. North America Interleukin 17A Revenue Market Share by Country in 2019
Figure 36. U.S. Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Interleukin 17A Market Share by Type in 2019
Figure 41. North America Interleukin 17A Market Share by Application in 2019
Figure 42. Europe Interleukin 17A Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Interleukin 17A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Interleukin 17A Sales Market Share by Country in 2019
Figure 45. Europe Interleukin 17A Revenue Market Share by Country in 2019
Figure 46. Germany Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Interleukin 17A Market Share by Type in 2019
Figure 57. Europe Interleukin 17A Market Share by Application in 2019
Figure 58. Asia Pacific Interleukin 17A Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Interleukin 17A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Interleukin 17A Sales Market Share by Region in 2019
Figure 61. Asia Pacific Interleukin 17A Revenue Market Share by Region in 2019
Figure 62. China Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Interleukin 17A Market Share by Type in 2019
Figure 85. Asia Pacific Interleukin 17A Market Share by Application in 2019
Figure 86. Latin America Interleukin 17A Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Interleukin 17A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Interleukin 17A Sales Market Share by Country in 2019
Figure 89. Latin America Interleukin 17A Revenue Market Share by Country in 2019
Figure 90. Mexico Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Interleukin 17A Market Share by Type in 2019
Figure 97. Latin America Interleukin 17A Market Share by Application in 2019
Figure 98. Middle East and Africa Interleukin 17A Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Interleukin 17A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Interleukin 17A Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Interleukin 17A Revenue Market Share by Country in 2019
Figure 102. Turkey Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Interleukin 17A Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Interleukin 17A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Interleukin 17A Market Share by Type in 2019
Figure 109. Middle East and Africa Interleukin 17A Market Share by Application in 2019
Figure 110. North America Interleukin 17A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Interleukin 17A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Interleukin 17A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Interleukin 17A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Interleukin 17A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Interleukin 17A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Interleukin 17A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Interleukin 17A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Interleukin 17A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Interleukin 17A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs